Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth- muscle cells

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 6, 1997, Pages 759-766

  Tahara, Atsuo ^a   Tomura, Yuichi ^a   Wada, Koh Ichi ^a   Kusayama, Toshiyuki ^a   Tsukada, Junko ^a   Ishii, Noe ^a   Yatsu, Takeyuki ^a   Uchida, Wataru ^a   Tanaka, Akihiro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Hyperplasia; Hypertrophy; Nonpeptide antagonist; Vascular smooth muscle cells; Vasopressin V(1A) receptor; YM087

Indexed keywords

ARGIPRESSIN; CONIVAPTAN; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASOPRESSIN ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; VASCULAR SMOOTH MUSCLE;

ANIMALS; BENZAZEPINES; BINDING, COMPETITIVE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CELL CULTURE TECHNIQUES; DNA; ENZYME ACTIVATION; HYPERPLASIA; HYPERTROPHY; MUSCLE, SMOOTH, VASCULAR; PROTEIN BIOSYNTHESIS; RATS; RECEPTORS, VASOPRESSIN; VASOPRESSINS;

EID: 0031405967     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199712000-00010     Document Type: Article

References (31)

1. Caramelo C, Okada K, Tsai P, Schrier RW. Phorbol esters and arginine vasopressin in vascular smooth muscle cell activation. Am J Physiol 1989;256:F875-81.
2. Geisterfer AAT, Owens GK. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells. Hypertension 1989;14:413-20.
3. 1a antagonist, on human vascular smooth muscle cells. Am J Physiol 1995;268:H404-10.
4. Granot Y, Van Putten V, Schrier RW. Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets. Biochem Biophys Res Commun 1990;168:566-73.
5. Kribben A, Wieder ED, Li X, et al. RA. AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C. Am J Physiol 1993;265:C939-45.
6. Chao TS, Byron KL, Lee KM, Villereal M, Rosner MR. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. J Biol Chem 1992;267:19876-83.
7. Granot Y, Erikson E, Fridman H, et al. Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells. J Biol Chem 1993;268:9564-9.
8. Pelech SL, Sanghera JS. Mitogen-activated protein kinases: versatile transducers for cell signaling. Trends Biochem Sci 1992;17:233-8.
9. L'Allemain G, Sturgill TW, Weber MJ. Defective regulation of mitogen-activated protein kinase activity in a 3T3 cell variant mitogenically nonresponsive to tetradecanoyl phorbol acetate. Mol Cell Biol 1991;11:1002-8.
10. Tsuda T, Kawahara Y, Ishida Y, Koide M. Shii K, Yokoyama M. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ Res 1992;71:620-30.
11. Laszlo FA, Laszlo F Jr, De Wied D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 1991;43:73-108.
12. Manning M, Sawyer WH. Design and uses of selective agonistic and antagonistic analogs of the neuropeptides oxytocin and vasopressin. Trends Neurosci 1984;7:8-9.
13. 1A and V2 receptor antagonist, in dogs. Eur J Pharmacol 1997;321:225-30.
14. Kimes BW, Brandt BL. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 1976;98:349-66.
15. 50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-108.
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
17. 3H]thymidine incorporation assay. J Immunol Methods 1994;170:211-24.
18. Russell WE, Bucher NLR. Vasopressin modulates liver regeneration in the Brattleboro rat. Am J Physiol 1983;245:321-4.
19. Rozengurt E. Legg A. Pettican P. Vasopressin stimulation of mouse 3T3 cell growth. Proc Natl Acad Sci U S A 1979;76:1284-7.
20. 1-vascular vasopressin receptors. Regul Pept 1992;38:1-11.
21. 1-selective antagonist. J Recept Res 1989;9:1-18.
22. 1) receptor characteristics in rat aortic smooth muscle cells. Am J Physiol 1991;261:H1927-36.
23. Ross R. The pathogenesis of atherosclerosis. N Engl J Med 1986; 314:488-500.
24. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986;58:427-44.
25. Bobik A, Campbell JH. Vascular derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacol Rev 1993;45:1-42.
26. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension 1991;18:III115-21.
27. Dzau VJ. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol 1984;6:S377-82.
28. Simon JS, Brody MJ, Kasson BG. Characterization of a vasopressin-like peptide in rat and bovine blood vessels. Am J Physiol 1992;262:H799-805.
29. Lincoln J, Loesch A, Burnstock G. Localization of vasopressin, serotonin and angiotensin II in endothelial cells of the renal and mesenteric arteries of the rat. Cell Tissue Res 1990;259:341-4.
30. Loesch A, Bodin P, Burnstock G. Colocalization of endothelin, vasopressin and serotonin in cultured endothelial cells of rabbit aorta. Peptides 1991;12:1095-103.
31. Loesch A, Tomlinson A, Burnstock G. Localization of arginine-vasopressin in endothelial cells of rat pulmonary artery. Anat Embryol (Berl) 1991;183:129-34.